Header cover image

Hong Kong (HSI) Biotech Industry Analysis

UpdatedMay 15, 2025
DataAggregated Company Financials
Companies52
  • 7D-1.5%
  • 3M45.1%
  • 1Y39.9%
  • YTDn/a

In the last week, the Biotech industry is down 5.9% with Innovent Biologics down the most at 10%. In contrast, HighTide Therapeutics has gained 73%. In the past year, the industry has gained 40%. Looking forward, earnings are forecast to grow by 44% annually.

Industry Valuation and Performance

Has the Hong Kong Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 15 May 2025HK$553.0bHK$61.6b-HK$11,837,331,364.9729.2x-46.7x9x
Sat, 12 Apr 2025HK$501.4bHK$58.1b-HK$10,821,518,059.1026.3x-46.3x8.6x
Mon, 10 Mar 2025HK$461.2bHK$52.5b-HK$16,893,132,103.3822.7x-27.3x8.8x
Wed, 05 Feb 2025HK$358.8bHK$52.3b-HK$17,392,018,984.2612.6x-20.6x6.9x
Fri, 03 Jan 2025HK$367.2bHK$51.9b-HK$17,241,784,830.0610.8x-21.3x7.1x
Sun, 01 Dec 2024HK$399.6bHK$52.3b-HK$17,390,148,785.7210.7x-23x7.6x
Tue, 29 Oct 2024HK$392.5bHK$52.3b-HK$17,891,036,991.3611.4x-21.9x7.5x
Thu, 26 Sep 2024HK$355.1bHK$53.0b-HK$18,425,985,001.9711x-19.3x6.7x
Sat, 24 Aug 2024HK$332.2bHK$53.4b-HK$18,895,611,066.0211x-17.6x6.2x
Mon, 22 Jul 2024HK$324.3bHK$49.6b-HK$19,438,335,694.2812.6x-16.7x6.5x
Wed, 19 Jun 2024HK$338.1bHK$49.7b-HK$19,469,839,436.0510.5x-17.4x6.8x
Fri, 17 May 2024HK$371.5bHK$49.9b-HK$19,423,587,854.2612.1x-19.1x7.4x
Sun, 14 Apr 2024HK$341.5bHK$49.6b-HK$19,926,257,322.4811x-17.1x6.9x
Tue, 12 Mar 2024HK$345.7bHK$47.3b-HK$20,415,595,754.9716.5x-16.9x7.3x
Thu, 08 Feb 2024HK$321.9bHK$47.2b-HK$20,396,378,333.6915.5x-15.8x6.8x
Sat, 06 Jan 2024HK$376.6bHK$47.1b-HK$20,327,490,552.0016.9x-18.5x8x
Mon, 04 Dec 2023HK$427.8bHK$47.0b-HK$20,310,389,111.0018.9x-21.1x9.1x
Wed, 01 Nov 2023HK$413.5bHK$45.0b-HK$18,757,275,840.0013.2x-22x9.2x
Fri, 29 Sep 2023HK$408.6bHK$44.9b-HK$19,123,315,931.0014.3x-21.4x9.1x
Sun, 27 Aug 2023HK$373.5bHK$39.2b-HK$20,093,496,287.0015.7x-18.6x9.5x
Tue, 25 Jul 2023HK$400.4bHK$35.4b-HK$23,308,003,844.0026x-17.2x11.3x
Thu, 22 Jun 2023HK$396.9bHK$35.5b-HK$23,362,967,980.0024.5x-17x11.2x
Sat, 20 May 2023HK$427.4bHK$36.2b-HK$23,905,842,911.0031x-17.9x11.8x
Mon, 17 Apr 2023HK$469.8bHK$37.1b-HK$24,226,204,473.0018.7x-19.4x12.7x
Wed, 15 Mar 2023HK$388.0bHK$33.2b-HK$36,421,384,339.0021.2x-10.7x11.7x
Fri, 10 Feb 2023HK$450.6bHK$35.0b-HK$35,367,953,982.0029.8x-12.7x12.9x
Sun, 08 Jan 2023HK$426.7bHK$34.6b-HK$34,879,667,099.0030.9x-12.2x12.3x
Tue, 06 Dec 2022HK$363.6bHK$33.4b-HK$33,663,153,817.0023.3x-10.8x10.9x
Thu, 03 Nov 2022HK$347.8bHK$33.4b-HK$32,116,950,613.0018.6x-10.8x10.4x
Sat, 01 Oct 2022HK$286.1bHK$34.0b-HK$32,506,419,134.0017.1x-8.8x8.4x
Mon, 29 Aug 2022HK$336.6bHK$33.6b-HK$37,916,598,169.0011.9x-8.9x10x
Wed, 27 Jul 2022HK$343.8bHK$32.9b-HK$46,314,226,342.0013.5x-7.4x10.5x
Fri, 24 Jun 2022HK$363.3bHK$33.1b-HK$46,647,965,449.0014.3x-7.8x11x
Sun, 22 May 2022HK$352.6bHK$34.1b-HK$45,992,673,559.0014.1x-7.7x10.3x
Price to Earnings Ratio

-7.7x


Total Market Cap: HK$352.6bTotal Earnings: -HK$45,992,673,559.00Total Revenue: HK$34.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Biotech Industry Price to Earnings3Y Average -17.8x202320242025
Current Industry PE
  • Investors are relatively neutral on the Hong Kong Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 9.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Revenues for these companies have grown 22% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Hong Kong Biotech compare with similar industries?

HK Market3.79%
Healthcare0.16%
Biotech-1.49%
Biotech-1.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2696 Shanghai Henlius BiotechHK$40.0012.7%
+HK$2.4b
119.8%PE24.5x
2171 CARsgen Therapeutics HoldingsHK$19.2824.5%
+HK$2.1b
216.1%PS248.5x
9995 RemeGenHK$41.206.2%
+HK$1.3b
26.2%PS10.7x
2142 HBM HoldingsHK$9.279.8%
+HK$653.3m
562.1%PE341.7x
1167 Jacobio Pharmaceuticals GroupHK$4.4020.9%
+HK$599.4m
137.8%PS20.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1952

HK$45.20

Everest Medicines

7D

-4.9%

1Y

85.6%

2256

HK$8.24

Abbisko Cayman

7D

7.0%

1Y

122.7%

9995

HK$41.20

RemeGen

7D

6.2%

1Y

26.2%

2171

HK$19.28

CARsgen Therapeutics Holdings

7D

24.5%

1Y

216.1%

2696

HK$40.00

Shanghai Henlius Biotech

7D

12.7%

1Y

119.8%

1801

HK$49.95

Innovent Biologics

7D

-3.4%

1Y

25.5%

2511

HK$3.33

HighTide Therapeutics

7D

42.9%

1Y

-51.7%

1672

HK$6.02

Ascletis Pharma

7D

-9.7%

1Y

333.1%

2410

HK$25.40

TYK Medicines

7D

-16.3%

1Y

n/a